Revisiting Influenza Vaccination Exemption.

Area of Science:

• Immunology
• Neurology
• Vaccinology

Background:

• Serious adverse events following immunizations are infrequent.
• Understanding the long-term implications of rare adverse events is crucial for vaccine confidence.

Observation:

• A case report details a patient experiencing a serious adverse neurologic event 2 weeks post-influenza vaccination 50 years ago.
• The patient had avoided subsequent influenza vaccinations due to this event.

Findings:

• After careful consideration of risks and benefits, the patient was re-vaccinated with the influenza vaccine.
• The patient experienced no adverse events during the season they were re-vaccinated.

Implications:

• This case suggests that individuals with a history of rare adverse events may be safely re-vaccinated after thorough risk-benefit assessment.
• Reassurance regarding vaccine safety can be provided to patients with a history of adverse events.
• This highlights the importance of individualized vaccine decision-making.